Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1680-1689

  Qi, Chen Feng ^a   Zhang, Ruihua ^b   Sun, Jiafang ^a   Li, Zhaoyang ^c   Shin, Dong Mi ^a,d   Wang, Hongsheng ^a   Kovalchuk, Alexander L ^a   Sakai, Tomomi ^a   Xiong, Huabao ^b   Kon, Ning ^b   Gu, Wei ^e   Morse, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^d Seoul National University   (South Korea)

^e New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

ARF BP1; B cell development; MYC; P53

Indexed keywords

ARF PROTEIN; IMMUNOGLOBULIN G1; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; P21 ACTIVATED KINASE 1; PROTEIN BAX; PROTEIN FOS; PROTEIN KINASE; PROTEIN KINASE PIM 3; PROTEIN MDM2; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONTROL; GENE FREQUENCY; GENOTYPE; HISTOPATHOLOGY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPLEEN CELL; TRANSCRIPTION INITIATION; UBIQUITINATION; WESTERN BLOTTING;

EID: 84888127469     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.09.009     Document Type: Article

References (20)

1. Chen D., Kon N., Li M., Zhang W., Qin J., Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005, 121:1071-1083.
2. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
3. Medrano S., Scrable H. Maintaining appearances - the role of p53 in adult neurogenesis. Biochem Biophys Res Commun 2005, 331:828-833.
4. Zhao X.D., Lim D.A., Brahmachary W.K., Carro M., Ludwig M.S.T., et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell 2009, 17:210-221.
5. Zhao X., Heng J.I., Guardavaccaro D., Jiang R., Pagano M., Guillemot F., et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol 2008, 10:643-653.
6. Kon N., Zhong J., Qiang L., Accili D., Gu W. Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. J Biol Chem 2012, 287:5102-5111.
7. Hao Z., Duncan G.S., Su Y.W., Li W.Y., Silvester J., Hong C., et al. The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med 2012, 209:173-186.
8. Qi C.F., Kim Y.S., Xiang S., Abdullaev Z., Torrey T.A., Janz S., et al. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. Int J Mol Sci 2012, 13:6204-6219.
9. Adhikary S., Marinoni F., Hock A., Hulleman E., Popov N., Beier R., et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005, 123:409-421.
10. Zhang X., Berger F.G., Yang J., Lu X. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J 2011, 30:2177-2189.
11. Park S.S., Kim J.S., Tessarollo L., Owens J.D., Peng L., Han S.S., et al. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res 2005, 65:1306-1315.
12. Rickert R.C., Roes J., Rajewsky K. B lymphocyte-specific, cre-mediated mutagenesis in mice. Nucleic Acids Res 1997, 25:1317-1318.
13. Qi C.F., Xiang S., Shin M.S., Hao X., Lee C.H., Zhou J.X., et al. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. Leuk Res 2006, 30:153-163.
14. Wang H., Ye J., Arnold L.W., McCray S.K., Clarke S.H. A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+B cells. J Immunol 2001, 167:1254-1262.
15. Shin D.M., Shaffer D.J., Wang H., Roopenian D.C., Morse H.C. NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. Cancer Res 2008, 68:9202-9211.
16. Hodgkin P.D., Lee J.H., Lyons A.B. B cell differentiation and isotype switching is related to division cycle number. J Exp Med 1996, 184:277-281.
17. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009, 106:3207-3212.
18. Lin C.Y., Loven J., Rahl P.B., Paranal R.M., Burge C.B., Bradner J.E., et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
19. Nie Z., Hu G., Wei G., Cui K., Yamane A., Resch W., et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012, 151:68-79.
20. Jung Y.S., Qian Y., Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010, 22:1003-1012.